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Summary: In 1970 Linus Pauling claimed that
vitamin C prevents and alleviates the episodes
of the common cold. Pauling was correct in con-
cluding from trials published up till then, that in
general vitamin C does have biological effects
on the common cold, but he was rather over-op-
timistic as regards the size of benefit. His quan-
titative conclusions were based on a single pla-
cebo-controlled trial on schoolchildren in a ski-
ing camp in the Swiss Alps, in which a signifi-
cant decrease in common cold incidence and du-
ration in the group administered 1 g/day of vi-
tamin C was found. As children in a skiing camp
are not a representative sample of the general
population, Pauling's extrapolation to the pop-
ulation at large was too bold, erring as to the
magnitude of the effect. Nevertheless, Pauling's
general conclusion that vitamin C has physio-
logical effects on the common cold is of major
importance as it conflicts with the prevailing
consensus that the only physiological effect of
vitamin C on human beings is to prevent scurvy.
Introduction
Between 1930 and 1960 various authors sug-
gested that vitamin C has beneficial effects on
the common cold [1-7]. However, these sugges-
tions had no effect on the general attitude to-
wards vitamin C, the physiological role of which
was considered to be the prevention of scurvy
alone. The issue became more popular after
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1970 when Linus Pauling, a dual Nobel laureate
(chemistry in 1954 and peace in 1962), wrote a
book in which he claimed that this vitamin both
prevents and alleviates common cold episodes
[8]. In 1971 Pauling carried out a meta-analysis
of four placebo-controlled trials and concluded
that it was highly unlikely that all the reported
benefits in the vitamin C groups could be as-
cribed to chance alone (p < 0.000022) [9].
After the publication of the 1970 book [8], a
number of trials were carried out to test Pauling's
hypotheses [7,10,11]. However, the interest in
the issue declined abruptly after the middle of
the 1970s (Fig. 1). In 1975, two highly influen-
tial reviews [12,13] and one particularly in-
fluential trial [14] were published; all three
papers concluded that there is no evidence that
vitamin C has effects on the common cold. Ap-
parently these three papers gave a strong impres-
sion that vitamin C has no effects on the com-
mon cold and caused the subsequent decrease in
the number of studies on the issue (Fig. 1).
In his reminiscences Pauling described the
psychological background to his common cold
book. After an acrimonious exchange of views
concerning the effects of vitamin C supplemen-
tation, Pauling became "sufficiently irritated" to
sit down and write a synthesis of the evidence
indicating that vitamin C is beneficial against
the common cold [15], After his 1970 book was
published, Pauling complained that many of his
critics had not read either his texts or the origi-
nal papers, giving several examples in support
of his accusation [16-18].
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Figure 1: Placebo-controlled studies in which ? 1 g/day of
vitamin C was regularly administered to the subjects. Regular
supplementation refers here to initiating supplementation with
healthy people and continuing over the occurring common cold
episodes. The number of studies published during two conse-
cutive years is combined and plotted for the first of the two
years. For the list of references to the trials, see [10, 11].
Three highly important reviews stated that
there was no valid evidence to conclude that
vitamin C has effects on colds [12,13,19]. These
reviews were recently shown to be flawed how-
ever [20, 21]. Furthermore, the particularly in-
fluential trial carried out at the National Insti-
tutes of Health in the USA found a statistically
significant difference between vitamin C and
placebo groups in favour of the vitamin, but the
difference was paradoxically ascribed to a break
in the double-blind [14]. Recently, it was shown
that such an interpretation is not valid, indicat-
ing that the differences between the study groups
were caused by the physiological effects of the
vitamin [22].
The results of the controlled trials are briefly
described in this paper and they are compared
with Pauling's conclusions.
The Effect on Common Cold Symptoms
Pauling suggested that 1 g/day or more would
be useful for treating colds [8,9]. The incidence
of the common cold is greater in children than
in adults and hence placebo-controlled trials
with children administered ? 1 g/day of vitamin
C are particularly interesting in seeking the ef-
fects of this vitamin. There are 10 study groups
satisfying these criteria, whose results show that
vitamin C alleviates common cold symptoms
(Table I). For the outcomes listed in Table I the
median decrease is 22%.
Evidently the main question should not be to
decide whether a decrease of 22% is clinically
important, but to identify the characteristics of
the groups of children in which the benefit is
great or small. Furthermore, as the original re-
sults are mean-values for a group of children, it
is also obvious that vitamin C is much more, and
much less, beneficial for some individual chil-
dren than suggested by the result of a single trial
or by the median of several trials.
Carr et al [29] found that vitamin C had a con-
siderable effect on twins living apart, but no ef-
1 All trials in the table were double-blind placebo-controlled studies. In all studies children
were randomly allocated to study groups, except for the Coulehan 1974 study [25], in which
children were allocated to study groups alternately by alphabetical order.
2 Relative effect: the difference between the outcomes in vitamin C and placebo groups
divided by the outcome in the placebo group. Statistical significance: *, p < 0.05.
3 Twins living together.
4 Twins living apart.
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fect on twins living together (Table I). An obvi-
ous interpretation of such a difference is that
twins living together exchanged their tablets to
a great extent, while twins living apart could not.
Moreover, it is noteworthy in Carr's study [29]
that the average duration of colds in both vita-
min C and placebo groups of twins living togeth-
er (5.4 days), was intermediate between the vi-
tamin C (4.9 days) and placebo (7.5 days) groups
of twins living apart, which also is consistent
with the notion that tablets were exchanged by
twins living together. Two other trials with chil-
dren found an increase in plasma [25] and urine
[27] vitamin C levels in the placebo (sic!) groups
even more directly indicating that tablet ex-
change may have taken place among playful
children under study conditions. Carr's sub-
group analysis (Table I) is particularly impor-
tant in suggesting that in some studies with chil-
dren the mischief of the subjects may have
caused underestimation of the true physiologi-
cal effect.
A further important question in the trials is the
baseline dietary vitamin C intake. Miller et al
[27] found that at the start of the study their sub-
jects excreted 0.2-0.3 g/day of vitamin C in
urine and the intake must have been even high-
er. The recommended intake for 7-14 year old
children is considerably lower at 45-50 mg/day
[31]. Ludvigsson et al [28] found no difference
in leukocyte vitamin C concentrations between
the vitamin and placebo groups, also indicating
that the dietary vitamin C intake was high. Con-
sequently, in some studies high dietary vitamin
C intake may have decreased the difference
between the study groups, and the effect thus
could be greater if the control group received
only the recommended amount of the vitamin.
Table I consists of trials in which vitamin C
was administered regularly and it is important
to consider to what extent the results can be
extrapolated to therapeutic supplementation
initiated after the onset of symptoms. Some stud-
ies with adults have reported benefit from ther-
apeutic supplementation [14,22,32,33]. Nev-
ertheless, in therapeutic trials there are addition-
al sources of variation in the results since a
delay in the initiation of the treatment and a short
treatment period not covering the entire episode
can both decrease the effect.
In a study with adult subjects, Asfora [33]
found that therapeutic supplementation of
6 g/day for 5 days decreased the average dura-
tion of the colds by 48% when the treatment was
initiated within 24 h of the onset of symptoms.
However, if supplementation was commenced
24-48 h after the onset of the cold, the decrease
was only 29%, and when the treatment was com-
menced still later there was no benefit. These
data thus suggest that therapeutic vitamin C sup-
plementation should be initiated as soon as pos-
sible after the first symptoms are observed.
Some of the therapeutic trials with adults
[34-36] found no consistent benefit from vita-
min C supplementation, but this might be attrib-
uted to a brief period of supplementation (2-3
days), which was considerably shorter than the
duration of cold episodes in the same studies
(5-8 days).
Even though it is clear that vitamin C has
physiological effects on common cold symp-
toms, the clinical significance of therapeutic
supplementation during cold episodes is still an
open question.
The Effect on Common Cold Incidence
Most of the controlled trials have found no sig-
nificant effect on the incidence of colds [10,11].
In the six largest trials there was no decrease in
common cold incidence in the vitamin C groups:
pooled rate ratio (RR) = 0.99 (95% CI
0.93-1.04) [37]. Large doses of vitamin C thus
have no meaningful effect on the number of
common cold episodes in the general population
of Western countries.
Nevertheless, it is possible that vitamin C in-
take has some effect on cold incidence in limit-
ed groups of people or in people under specific
conditions. It recently was shown that in three
studies with subjects under heavy acute physi-
cal stress [38] there was a significant decrease
in cold incidence in groups supplemented with
vitamin C: RR = 0.50 (95% CI 0.35-0.69). In
four studies with British men [37] there was
also a significant decrease in cold incidence in
the vitamin C groups: RR = 0.70 (95% CI 0.60-
0.81). In addition to the studies falling into these
two groups some other studies have found sta-
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tistically significant preventive effects with vi-
tamin C supplementation (1-tailed p).
In their 1942 study with schoolchildren
Cowan et al [39] found a 15% lower incidence
of colds in the group supplemented with 0.1-
0.2 g/day of vitamin C (p < 0.02 [9]). In a study
carried out in 1971 with miners in Czechoslo-
vakia, Masek et al [40] found a 22% lower in-
cidence of colds in a group supplemented with
0.1 g/day of vitamin C (p < 0.02); however, the
control group was not administered placebo. In
their 1972 study Anderson et al [41,42] found
a 21% lower incidence of "throat colds"
(p < 0.01 [37]) in the vitamin C group (1 g/day),
but there was no difference in the incidence of "-
nose colds". Bancalari et al [30] reported a sig-
nificantly smaller number of "recurrent colds" in
schoolchildren administered 2 g/day of vitamin C.
Another outcome reflecting the preventive ef-
fects of vitamin C supplementation is the pro-
portion of subjects remaining free of illness dur-
ing the study. In their study in 1972 [41] Ander-
son et al found that 26% of subjects remained
free of illness in the 1 g/day vitamin C group,
whereas in the placebo group 18% remained free
of illness (p = 0.006 [37]). Coulehan [25] found
that among schoolchildren of lower grades 32%
remained free of illness in the 1 g/day vitamin
C group, whereas in the placebo group only 16%
did so (p = 0.0001 [21]). Also a significant pre-
ventive benefit from the vitamin C in children
of the upper grades was found [25], but this was
smaller, 63% as against 49% remaining free of
illness (p = 0.02) [21].
The strongest evidence indicating that vita-
min C intake has a physiological effect on sus-
ceptibility to colds comes from the studies with
subjects under acute heavy physical stress [38]
and with British men [37]. While a few other
studies are compatible with the notion that reg-
ular vitamin C supplementation may be benefi-
cial for certain people, it seems clear that in the
general population large doses have no substan-
tial effect on the number of cold episodes [37].
Was Linus Pauling Right or Wrong?
As regards the effects of vitamin C on the com-
mon cold, Pauling drew conclusions at various
different levels. At the general level he claimed
that vitamin C has biological effects on the in-
cidence and severity of the common cold [8,9].
The results published so far indicate that these
general conclusions were correct. They do how-
ever conflict markedly with the prevailing con-
sensus that the only physiological effect of vi-
tamin C in human beings is to prevent scurvy.
For example, the nutritional recommendations
are concerned with the prevention of scurvy
alone and the recommended intake levels are not
based on controlled trials or epidemiological
studies indicating that such levels are optimum
amounts in the long term [18,31,43-50]. In this
respect Pauling's general conclusions were of
major importance in challenging the nutritional
paradigm focused on scurvy alone.
Nevertheless, with respect to specific conclu-
sions as to the size of the effect, Pauling was
grossly over-enthusiastic. Pauling [9] based his
estimates of the benefit on a trial published in
1961, carried out by Ritzel [23] with schoolboys
in a skiing camp in the Swiss Alps. When Paul-
ing [9] considered the topic, this particular trial
was the only placebo-controlled study in which
1 g/day of vitamin C had regularly been given
to subjects. Technically it was a well designed
study as it was randomized, double-blind and
placebo-controlled [23,24]. Pauling put great
weight on it and extrapolated the findings to the
general population. He modeled the dose-
dependency of the effects of vitamin C supple-
mentation with exponential formulas in which
constants were based on Ritzel's data. Pauling
assumed that the main problem in his estimates
was the inaccuracy caused by the "experimen-
tal error," although he also noted that "the val-
ues are, of course, expected to depend somewhat
on the nature of the population and environ-
ment" [9]. However, even with these prudent
reservations Pauling's conclusions were all too
optimistic. He could not imagine how great the
variations in the results would be in the forth-
coming trials. Neither did Pauling consider the
possibility that the effects observed by Ritzel
[23] were caused, at least in part, by low dietary
vitamin C intake, in which case a smaller dose
could have produced a similar benefit. Pauling
attributed the difference between the study
groups solely to the large dose given to the treat-
ment group [9].
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Ritzel found that cold symptoms in the vita-
min C group were 29% shorter [9,17,23]. This
is quite comparable with the results found in
other trials with children (Table I), so that the
decrease observed by Ritzel [23] seems to be
biologically meaningful. However, in adults the
benefit has usually been much smaller. In a
large-scale study recording 1317 cold episodes
among 688 adult women, Elwood et al [51]
found only a 6% decrease in the duration of colds
with 1 g/day of the vitamin. Furthermore, Kar-
lowski et al [14,22] administered 3 g/day reg-
ularly to adults, but the duration of colds was
reduced by just 6%. It thus seems that the ex-
trapolation of Ritzel's finding to the general pop-
ulation was a major reason for the great discrep-
ancy between Pauling's quantitative predictions
[9] and the effects seen in later trials carried out
largely with adults [10].
Ritzel found a 45% lower incidence of colds
in the vitamin C group [9,17,23]. This study
belongs to the group of four that used subjects
under acute heavy physical stress, and in each
of these studies a substantial decrease in com-
mon cold incidence was reported with vitamin
C supplementation [38]. Consequently, Ritzel's
finding seems biologically meaningful also in
this case. However, Pauling's [9] extrapolation
of this finding to the general population led him
into error [37]. It is not clear to what extent
Ritzel's results are attributable to the heavy
stress and to what extent to relatively poor nu-
trition in the skiing camp, but Ritzel's result on
incidence was positive because of the particular
experimental conditions and therefore the find-
ing cannot be extrapolated to the general popu-
lation.
As regards the errors in Pauling's quantitative
conclusions, it should obviously be taken into
account that most of the trials available today
were carried out after Pauling worked on the top-
ic, and even more importantly, they were carried
out precisely because Pauling made the issue
popular. Without bold intellectual leaps and pro-
vocative hypotheses progress in science is slow
or non-existent. In this respect the accuracy of
Pauling's extrapolation from the single placebo-
controlled trial using regular 1 g/day supplemen-
tation available in the early 1970s is not parti-
cularly relevant.
Pauling was highly energetic and he was also
interested in the role of vitamins in treating men-
tal disorders [44] and in the role of vitamin C in
treating cancer [52-55], as well as in problems
of structural chemistry. It seems that because of
his numerous other activities Pauling left the
common cold issue largely unfinished and was
not confronted with the fact that in the later trials
the observed benefits were considerably small-
er than he predicted. Pauling also adhered
strongly to the idea of regular supplementation
which led him to analyze the results by calcu-
lating the "integrated morbidity," which is the
product of the incidence and duration of colds
[9,17,18]. However, the effects of vitamin C
supplementation on incidence and duration
show very different patterns and it seems to be
much more fruitful to analyze these effects sep-
arately.
Retrospectively it seems surprising that Paul-
ing did not point out the shortcomings in
Chalmers' review [12,20] or the flaws in the
interpretation of Karlowski's trial [14,22]. Paul-
ing did write two papers [56,57] in which he
pointed out certain shortcomings of the Dykes
and Meier review [13]. However, there are im-
portant flaws in Dykes and Meier's review that
were not pointed out by Pauling [21].
The trials carried out after Pauling wrote his
1970 book "Vitamin C and the common cold"
have consistently found that vitamin C allevi-
ates common cold symptoms (Table I; [10,11,
21]). In this respect Pauling's opponents were
not flexible enough in maintaining that vitamin
C has no effect on colds. It seems that the oppo-
sition to Pauling's conclusions was not so much
caused by the inaccuracy of his estimates, but
rather because of disagreements at the "para-
digm" level [21,46,47]. There are several ex-
amples of efficacious therapies being rejected
because they did not "make sense" in the light
of accepted theories of disease mechanism and
drug action, the phenomenon being designated
the "tomato effect" [58]. Such a strong adher-
ence to the scurvy paradigm may explain the bias
in several reviews [20,21] and the flawed inter-
pretation of the Karlowski study results as well
[22]. Nevertheless, the suggestions that vitamin
C may have effects on the immune system go
back to the 1930s [59-64], and in this respect
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the question of whether it "makes sense" that vi-
tamin C has effects on the common cold may
largely depend on the degree of familiarity with
the immunological literature. None of the three
major reviews [12,13,19] cited original papers
or reviews dealing with the possible effects of
vitamin C on the immune system.
Conclusion
Although controlled trials have shown that vita-
min C does have physiological effects on the
common cold, there are a number of open ques-
tions still awaiting answers: what is the best
method of supplementation, what are the maxi-
mum treatment effects, how does the benefit
vary in different groups of subjects, etc? Obvi-
ously, answering such questions demands fur-
ther controlled trials.
It seems reasonable to assume that the effects
of vitamin C on the common cold are caused by
nonspecific effects on the immune system.
There seems to be no reason to think that vita-
min C has effects specific to the common cold,
which in fact is caused by half a dozen unrelat-
ed viruses with some 200 serotypes. Conse-
quently, it is not surprising that a few reports in-
dicate that vitamin C intake may have effects on
the prevention and treatment of other infections
[65]. Finally, there is evidence that in humans
vitamin C has physiological effect unrelated to
both scurvy as well as infections [18,43-45,49,
50,52-54,66-70]. Even though such effects are
presumably modest in size, it would seem worth-
while to examine such effects in more detail
since vitamin C is a cheap substance and safe
even in large doses [18, 68-72], so that a cost
benefit ratio may be meaningful even with mod-
est effects.
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